The combi-targeting concept: Mechanism of action of the pleiotropic combi-molecule RB24 and discovery of a novel cell signaling-based combination principle-Reference-Cited by-同舟云学术

The combi-targeting concept: Mechanism of action of the pleiotropic combi-molecule RB24 and discovery of a novel cell signaling-based combination principle

Published:2011-04 Issue:4 Volume:23 Page:630-640
ISSN:0898-6568
Container-title:Cellular Signalling
language:en
Short-container-title:Cellular Signalling

Author:

Banerjee Ranjita,Huang Ying,Qiu Qiyu,Mcnamee James P.,Belinsky Gina,Jean-Claude Bertrand J.

Funder

United States Department of Defense Congressionally-Directed Medical Research Program (CDMRP)/Prostate Cancer Research Program and Prostate Cancer

Canadian Cancer Society Research Institute (CCSRI)

McGill University Health Center Research Institute

Publisher

Elsevier BV

Subject

Cell Biology

Reference49 articles.

1. Epidermal growth factor receptor inhibitors in cancer treatment

2. Studies of the HER-2/ neu Proto-Oncogene in Human Breast and Ovarian Cancer

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Molecular Analysis of the Superior Efficacy of a Dual Epidermal Growth Factor Receptor (EGFR)-DNA-Targeting Combi-Molecule in Comparison with Its Putative Prodrugs 6-Mono-Alkylamino- and 6,6-Dialkylaminoquinazoline in a Human Osteosarcoma Xenograft Model;Cells;2023-03-16

2. Quantitative Analysis of the Potency of Equimolar Two-Drug Combinations and Combi-Molecules Involving Kinase Inhibitors In Vitro: The Concept of Balanced Targeting;International Journal of Molecular Sciences;2021-09-03

3. Design and Mechanism of Action of a New Prototype of Combi-Molecule “Programed” to Release Bioactive Species at a pH Range Akin to That of the Tumor Microenvironment;Pharmaceuticals;2021-02-16

4. Comparative analysis of the dual EGFR-DNA targeting and growth inhibitory properties of 6-mono-alkylamino- and 6,6-dialkylaminoquinazoline-based type II combi-molecules;European Journal of Medicinal Chemistry;2020-04

5. Anticancer Triazenes: from Bioprecursors to Hybrid Molecules;Current Pharmaceutical Design;2019-08-16